1:
Katayama Y, Tanaka K, Nakao S, Tachino J, Hirose T, Dohmi H, Kitamura T, Oda J, Matsuoka T. Factors associated with difficulty in hospital acceptance during the COVID-19 pandemic period in Osaka Prefecture, Japan: a population-based study. Front Public Health. 2024;12:1391519. doi: 10.3389/fpubh.2024.1391519. eCollection 2024. PubMed PMID: 38873305; PubMed Central PMCID: PMC11171416.
2:
Katayama Y, Tanaka K, Domi H, Masui J, Nakao S, Tachino J, Hirose T, Kitamura T, Oda J, Matsuoka T. Outcome of emergency patients transported by ambulance during the COVID-19 pandemic in Osaka Prefecture, Japan: a population-based descriptive study. Front Public Health. 2023;11:1322236. doi: 10.3389/fpubh.2023.1322236. eCollection 2023. PubMed PMID: 38274542; PubMed Central PMCID: PMC10808805.
3:
Nakao S, Katayama Y, Kitamura T, Tanaka K, Hirose T, Tachino J, Iwami T, Masui J, Domi H, Shimazu T, Oda J, Matsuoka T. Assessing the impact of COVID-19 pandemic on ambulance transports for self-harm: a population-based study in Osaka Prefecture, Japan. BMJ Open. 2023 Sep 12;13(9):e074903. doi: 10.1136/bmjopen-2023-074903. PubMed PMID: 37699632; PubMed Central PMCID: PMC10503339.
4:
Tanaka K, Katayama Y, Kitamura T, Dohmi H, Masui J, Hirose T, Nakao S, Tachino J, Zha L, Sobue T, Oda J, Matsuoka T. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Emergency Patients Hospitalized With Cardiocerebrovascular Diseases in Osaka Prefecture, Japan - A Population-Based Study. Circ J. 2023 Aug 25;87(9):1240-1248. doi: 10.1253/circj.CJ-23-0298. Epub 2023 Aug 1. PubMed PMID: 37532531.
5:
Katayama Y, Tanaka K, Kitamura T, Dohmi H, Masui J, Hirose T, Nakao S, Tachino J, Oda J, Matsuoka T. Incidence and outcome of patients with difficulty in hospital acceptance during COVID-19 pandemic in Osaka Prefecture, Japan: A population-based descriptive study. Acute Med Surg. 2023 Jan-Dec;10(1):e880. doi: 10.1002/ams2.880. eCollection 2023 Jan-Dec. PubMed PMID: 37564634; PubMed Central PMCID: PMC10410119.
6:
Takahashi Y, Matsuura H, Domi H, Yamamura H. A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19. Clin Diabetes Endocrinol. 2022 Apr 27;8(1):4. doi: 10.1186/s40842-022-00141-2. PubMed PMID: 35477646; PubMed Central PMCID: PMC9044380.
7:
Domi H, Matsuura H, Kuroda M, Yoshida M, Yamamura H. Simple prognostic factors and change of inflammatory markers in patients with severe coronavirus disease 2019: a single-center observational study. Acute Med Surg. 2021 Jan-Dec;8(1):e683. doi: 10.1002/ams2.683. eCollection 2021 Jan-Dec. PubMed PMID: 34277014; PubMed Central PMCID: PMC8275370.
8:
Yamamura H, Matsuura H, Nakagawa J, Fukuoka H, Domi H, Chujoh S. Effect of favipiravir and an anti-inflammatory strategy for COVID-19. Crit Care. 2020 Jul 9;24(1):413. doi: 10.1186/s13054-020-03137-5. PubMed PMID: 32646499; PubMed Central PMCID: PMC7347251.
